Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
BAY-8400 is an inhibitor of DNA-dependent protein kinase (DNA-PK; IC50 = 0.081 µM).1 It is selective for DNA-PK over ataxia-telangiectasia mutated kinase (ATM) and mTOR (IC50s = 19.3 and 1.91 µM, respectively) and a panel of 365 additional kinases at 1 µM but does inhibit ataxia-telangiectasia and Rad3-related protein/kinase (ATR) and PI3Kβ (IC50s = 0.394 and 0.117 µM, respectively). BAY-8400 inhibits the formation of γH2AX in ATM-negative HT-144 melanoma cells (IC50 = 0.069 nM) and reduces the proliferation of HT-29 colon cancer cells when used alone or in combination with bleomycin. In vivo, BAY-8400 (150 mg/kg, p.o.) reduces tumor area in an LNCaP prostate cancer mouse xenograft model when administered in combination with BAY 2315497.
WARNING This product is not for human or veterinary use.
1. BAY-